Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies

Journal of the National Cancer Institute

Volumn 103, Issue 21, 2011, Pages 1588-1595

  Calboli, Federico C F ^a   Cox, David G ^a,b   Buring, Julie E ^c   Gaziano, J Michael ^c   Ma, Jing ^c   Stampfer, Meir ^c,d,e   Willett, Walter C ^c,d,e   Tworoger, Shelley S ^c,d   Hunter, David J ^c,d,e   Camargo, Carlos A ^c,f   Michaud, Dominique S ^a,g  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CENTRE LÉON BÉRARD   (France)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Harvard Medical School ^*  (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOOD ALLERGEN; IMMUNOGLOBULIN E;

ADULT; AGED; ALLERGIC ASTHMA; ALLERGY; ARTICLE; ASTROCYTOMA; CANCER DIAGNOSIS; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EPENDYMOMA; FEMALE; FLUORESCENCE ANALYSIS; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ALLERGENS; ASTHMA; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GLIOMA; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 80655144777     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr361     Document Type: Article

References (20)

1. CBTRUS (2010). CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2006. Source: Central Brain Tumor Registry of the United States, Hinsdale, IL. www.cbtrus.org.
2. SEER Cancer Statistics Review 1975-2007. http://seer.cancer.gov/csr/1975- 2007/index.html.
3. Linos E, Raine T, Alonso A, et al. Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst. 2007;99(20):1544-1550. (Pubitemid 351767237)
4. Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4(4):278-299.
5. Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med. 2001;344(1):30-37. (Pubitemid 32064843)
6. Harling-Berg CJ, Park TJ, Knopf PM. Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation. J Neuroimmunol. 1999;101(2):111-127. (Pubitemid 29516453)
7. Stampfer MJ, Buring JE, Willett W, et al. The 2 x 2 factorial design: its application to a randomized trial of aspirin and carotene in U.S. physicians. Stat Med. 1985;4(2):111-116. (Pubitemid 15055340)
8. Belanger CF, Hennekens CH, Rosner B, et al. The Nurses' Health Study. Am J Nurs. 1978;78(6):1039-1040.
9. Buring JE, Hennekens CH; for The Women's Health Study Research Group. The Women's Health Study: summary of the study design. J Myocardial Ischemia. 1992;4:27-29.
10. Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991;338(8765):464-468.
11. Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol. 1994;140(11):1016- 1019. (Pubitemid 24373006)
12. Walker PR, Calzascia T, Dietrich PY. All in the head: obstacles for immune rejection of brain tumours. Immunology. 2002;107(1):28-38.
13. Szeinbach SL, Barnes JH, Sullivan TJ, et al. Precision and accuracy of commercial laboratories' ability to classify positive and/or negative allergen-specific IgE results. Ann Allergy Asthma Immunol. 2001;86(4):373-381. (Pubitemid 32332314)
14. Paganelli R, Ansotegui IJ, Sastre J, et al. Specific IgE antibodies in the diagnosis of atopic disease. Clinical evaluation of a new in vitro test system, UniCAP, in six European allergy clinics. Allergy. 1998;53(8):763-768. (Pubitemid 28374757)
15. Henderson CE, Ownby D, Klebanoff M, et al. Stability of immunoglobulin E (IgE) in stored obstetric sera. J Immunol Methods. 1998;213(1):99-101. (Pubitemid 28376598)
16. Wiemels JL, Wiencke JK, Sison JD, et al. History of allergies among adults with glioma and controls. Int J Cancer. 2002;98(4):609-615. (Pubitemid 34208564)
17. Wiemels JL, Wiencke JK, Patoka J, et al. Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res. 2004;64(22):8468-8473. (Pubitemid 39491789)
18. Wiemels JL, Wilson D, Patil C, et al. IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int J Cancer. 2009;125(3):680-687.
19. Christensen BC, Smith AA, Zheng S, et al. DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. J Natl Cancer Inst. 2011;103(2):143-153.
20. Miranda C, Busacker A, Balzar S, et al. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol. 2004;113(1):101-108. (Pubitemid 38096168)